Learn how donor-derived cell-free DNA (dd-cfDNA) offers a minimally invasive, sensitive approach for early detection of graft ...

Discover how voided urine cfDNA emerges as a promising biomarker for upper tract urothelial carcinoma, offering a less ...

NIPT is an early blood test that screens for Down syndrome and other conditions – and it can tell you your baby's gender.

Many moms-to-be opt for blood tests during pregnancy to check for fetal disorders such as Down syndrome. In rare instances, ...

▲ 点击上方蓝字关注CellPress细胞科学 ▲生命科学Life science自人类基因组计划以来，科学家不断探索疾病、健康与长寿的遗传奥秘，逐步构建起以千人基因组计划、UK Biobank、TOPMed、All of ...

A new prenatal test offered accurate, noninvasive fetal RHD determination starting at nine weeks of pregnancy.

Almost half of pregnant or postpartum women with unusual or nonreportable clinical cell-free (cf)DNA-sequencing results have occult cancer.

Early detection of fetal Rhesus D (RhD) status and possible hemolytic disease of the fetus and newborn (HDFN) via a noninvasive cell-free DNA (cfDNA) screening test has been adopted widely in ...

Many moms-to-be opt for blood tests during pregnancy to check for fetal disorders such as Down syndrome. In rare instances, these tests can reveal something unexpected — hints of a hidden cancer in ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced the enrollment of the first patients in the SAGITTARIUS clinical trial. Sponsored by The AIRC ...

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening.

Researchers have revealed how the folding and movement of DNA that brings distant regions closer together is linked to bursts ...